CSIMarket
 


Adapthealth Corp   (AHCO)
Other Ticker:  
 
    Sector  Healthcare    Industry Healthcare Facilities
   Industry Healthcare Facilities
   Sector  Healthcare
 

AHCO's Capital Expenditures Growth by Quarter and Year

Adapthealth 's Capital Expenditures results by quarter and year




AHCO Capital Expenditures (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December 88.65 142.91 63.62 16.92
III Quarter September 77.09 94.17 60.29 11.92
II Quarter June 82.61 77.17 43.80 3.38
I Quarter March 89.12 77.17 35.60 7.53
FY   337.47 391.42 203.31 39.75



AHCO Capital Expenditures fourth quarter 2023 Y/Y Growth Comment
Adapthealth Corp reported fall in Capital Expenditures in the fourth quarter 2023 by -37.97% to $ 88.65 millions, from the same quarter in 2022.
The drop in the fourth quarter 2023 Adapthealth Corp 's Capital Expenditures compares unfavorably to the Company's average Capital Expenditures doubling of 190.48%.

Among companies who have reported fourth quarter 2023 results in the Healthcare Facilities industry only one Company has achieved higher year on year Capital Expenditures results in the fourth quarter 2023. While Adapthealth Corp ' s Capital Expenditures drop of -37.97% ranks overall at the positon no. 380 in the fourth quarter 2023.




AHCO Capital Expenditures ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December -37.97 % 124.63 % 276 % -20.68 %
III Quarter September -18.14 % 56.2 % 405.79 % -
II Quarter June 7.05 % 76.19 % 1195.86 % -
I Quarter March 15.49 % 116.77 % 372.78 % -
FY   -13.78 % 92.52 % 411.47 % 86.36 %

Financial Statements
Adapthealth 's fourth quarter 2023 Capital Expenditures $ 88.65 millions AHCO's Income Statement
Adapthealth 's fourth quarter 2022 Capital Expenditures $ 142.91 millions Quarterly AHCO's Income Statement
New: More AHCO's historic Capital Expenditures Growth >>


AHCO Capital Expenditures (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December 14.99 % 51.76 % 5.52 % 41.95 %
III Quarter September -6.68 % 22.03 % 37.65 % 252.66 %
II Quarter June -7.3 % 0 % 23.03 % -55.11 %
I Quarter March -37.64 % 21.3 % 110.4 % -64.7 %
FY (Year on Year)   -13.78 % 92.52 % 411.47 % 86.36 %




Capital Expenditures fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #2
Healthcare Sector #43
Overall #380

Capital Expenditures Y/Y Growth Statistics
High Average Low
800.09 % 190.48 % -13.79 %
(Mar 31 2021)   (Dec 31 2023)
Capital Expenditures fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #2
Healthcare Sector #43
Overall #380
Capital Expenditures Y/Y Growth Statistics
High Average Low
800.09 % 190.48 % -13.79 %
(Mar 31 2021)   (Dec 31 2023)

Capital Expenditures by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Adapthealth 's Q/Q Capital Expenditures Growth


Capital Expenditures Q/Q Growth Statistics
High Average Low
252.57 % 25.61 % -64.68 %
(Sep 30 2020)  


AHCO's IV. Quarter Q/Q Capital Expenditures Comment
Adapthealth Corp achieved in the IV. Quarter 2023 below company average Capital Expenditures rise of 14.99% quarter on quarter, to $ 88.65 millions.

Within Healthcare Facilities industry 10 other companies have achieved higher Capital Expenditures quarter on quarter growth. While Adapthealth 's Capital Expenditures growth quarter on quarter, overall rank is 658.


Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #11
Healthcare Sector #94
Overall #658
Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #11
Healthcare Sector #94
Overall #658
Capital Expenditures Q/Q Growth Statistics
High Average Low
252.57 % 25.61 % -64.68 %
(Sep 30 2020)  


AHCO's IV. Quarter Q/Q Capital Expenditures Comment
Adapthealth Corp achieved in the IV. Quarter 2023 below company average Capital Expenditures rise of 14.99% quarter on quarter, to $ 88.65 millions.

Within Healthcare Facilities industry 10 other companies have achieved higher Capital Expenditures quarter on quarter growth. While Adapthealth 's Capital Expenditures growth quarter on quarter, overall rank is 658.


Adapthealth 's 12 Months Capital Expenditures Growth Year on Year


Capital Expenditures TTM Growth

12 Months Ending
(Dec 31 2023)
12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
Cumulative Capital Expenditures 12 Months Ending $ 337.46 $ 391.73 $ 408.81 $ 403.38 $ 391.42
Y / Y Capital Expenditures Growth (TTM) -13.79 % 25.5 % 46.92 % 64.73 % 92.53 %
Year on Year Capital Expenditures Growth Overall Ranking # 88 # 107 # 179 # 83 # 53
Seqeuential Capital Expenditures Change (TTM) -13.85 % -4.18 % 1.35 % 3.05 % 25.4 %
Seq. Capital Expenditures Growth (TTM) Overall Ranking # 443 # 1135 # 879 # 913 # 764




Cumulative Capital Expenditures growth Comment
For the 12 months ended Dec 31 2023 Adapthealth reported a decline in Capital Expenditures by -13.79% year on year, to $337 millions, compare to the 25.5% growth at Sep 30 2023.

Among companies within the Healthcare sector 13 other companies have achieved higher trailing twelve month Capital Expenditures growth. While Total ranking has impoved so far to 88, from total ranking in previous quarter at 107.

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
800.09 %
190.48 %
-13.79 %
 

Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 2
Healthcare Sector # 14
Overall # 88

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
800.09 %
190.48 %
-13.79 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry # 2
Sector # 51
S&P 500 # 443
Cumulative Capital Expenditures growth Comment
For the 12 months ended Dec 31 2023 Adapthealth reported a decline in Capital Expenditures by -13.79% year on year, to $337 millions, compare to the 25.5% growth at Sep 30 2023.

Among companies within the Healthcare sector 13 other companies have achieved higher trailing twelve month Capital Expenditures growth. While Total ranking has impoved so far to 88, from total ranking in previous quarter at 107.

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
800.09 %
190.48 %
-13.79 %
 


Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 2
Healthcare Sector # 14
Overall # 88

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
800.09 %
190.48 %
-13.79 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry # 2
Sector # 51
S&P 500 # 443




Other Capital Expenditures Growth
Healthcare Facilities Industry Capital Expenditures Growth Trends and Statistics
Healthcare Sector Capital Expenditures Growth Statistics
Capital Expenditures Growth Trends for overall market
AHCO's Capital Expenditures Growth Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Capital Expenditures Growth
Lowest Ranking Capital Expenditures Growth
Capital Expenditures Growth for AHCO's Competitors
Capital Expenditures Growth for Adapthealth 's Suppliers
Capital Expenditures Growth for AHCO's Customers

You may also want to know
AHCO's Annual Growth Rates AHCO's Profitability Ratios AHCO's Asset Turnover Ratio AHCO's Dividend Growth
AHCO's Roe AHCO's Valuation Ratios AHCO's Financial Strength Ratios AHCO's Dividend Payout Ratio
AHCO's Roa AHCO's Inventory Turnover Ratio AHCO's Growth Rates AHCO's Dividend Comparisons



Companies with similar Capital Expenditures decline for the quarter ending Dec 31 2023 within Healthcare SectorY/Y Change %Capital Expenditures for the quarter ending Dec 31 2023
Sunshine Biopharma Inc -0.43%$ -0.431 millions
Infusystem Holdings Inc -0.73%$ -0.730 millions
Stereotaxis Inc -0.81%$ -0.813 millions
Icon Plc-1.03%$ -1.033 millions
Alpine Immune Sciences Inc -1.72%$ -1.724 millions
Argenx se-2.99%$ -2.987 millions
Abbvie inc -3.76%$ -3.756 millions
Vanda Pharmaceuticals Inc -3.80%$ -3.802 millions
Warby Parker Inc -4.52%$ -4.516 millions
Bristol myers Squibb Company-4.62%$ -4.624 millions
Baxter International Inc -5.00%$ -5.000 millions
Progyny Inc -5.55%$ -5.548 millions
Precipio inc -5.77%$ -5.769 millions
Koru Medical Systems Inc-6.92%$ -6.916 millions
Ufp Technologies Inc -7.02%$ -7.018 millions
Bio rad Laboratories Inc -7.27%$ -7.272 millions
Endo International Plc-8.13%$ -8.130 millions
Eterna Therapeutics Inc -9.52%$ -9.524 millions
Sotera Health Company-9.63%$ -9.633 millions
Hutchmed china Limited-11.05%$ -11.052 millions
Biolinerx Ltd -11.45%$ -11.450 millions
Petvivo Holdings Inc-11.46%$ -11.461 millions
Novartis Ag-11.52%$ -11.519 millions
Charles River Laboratories International inc -12.02%$ -12.020 millions
Surgery Partners Inc -12.78%$ -12.775 millions
Xbiotech Inc -12.88%$ -12.879 millions
Cardiol Therapeutics inc -13.92%$ -13.917 millions
Conmed Corporation-14.46%$ -14.464 millions
Msa Safety Incorporated-14.60%$ -14.601 millions
Teva Pharmaceutical Industries Limited-16.20%$ -16.197 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com